Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 Study)

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 3, 2013, Pages

  Moureau Zabotto, Laurence ^a   Ortholan, Cecile ^b   Hannoun Levi, Jean Michel ^c   Teissier, Eric ^d   Cowen, Didier ^e,f   Salem, Nagi ^a   Lemanski, Claire ^g   Ellis, Steve ^h   Resbeut, Michel ^a,h  

^a INSTITUT PAOLI CALMETTES   (France)

^b Department of Radiation Therapy ^*  (Monaco)

^c CENTRE ANTOINE LACASSAGNE   (France)

^d Azurean Cancer Center   (France)

^e North Hospital   (France)

^f CENTRE VAL D AURELLE   (France)

^g Catalan Oncology Center   (France)

^h French Red Cross Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANAL CANCER; BRACHYTHERAPY; CLINICAL OUTCOME; COLOSTOMY-FREE SURVIVAL; EXTERNAL BEAM RADIATION THERAPY; HAZARD RATIO; LOCAL RECURRENCE; LYMPH NODE; MEAN DOSE; MULTI VARIATE ANALYSIS; NODAL STATUS; OVERALL SURVIVAL RATES; PROGNOSTIC FACTORS; PROSPECTIVE RANDOMIZED TRIAL; SQUAMOUS CELL CARCINOMA; TUMOR STAGING;

BODY FLUIDS; DISEASES; ONCOLOGY; TUMORS;

RADIOTHERAPY;

ADULT; AGED; ANUS CARCINOMA; ANUS SQUAMOUS CELL CARCINOMA; ARTICLE; BRACHYTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; COLOSTOMY FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANAL CANAL; ANUS NEOPLASMS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR BURDEN; VAGINAL NEOPLASMS;

EID: 84873314174     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.09.034     Document Type: Article

References (20)

1. M.H. Whiteford, K.R. Stevens Jr., and S. Oh The evolving treatment of anal cancer: how are we doing? Arch Surg 136 2001 886 891
2. N.D. Nigro, V.K. Vaitkevicius, and B. Considine Jr. Combined therapy for cancer of the anal canal: a preliminary report Dis Colon Rectum 17 1974 354 356
3. J. Papillon Effectiveness of combined radio-chemotherapy in the management of epidermoid carcinoma of the anal canal Int J Radiat Oncol Biol Phys 19 1990 1217 1218
4. H. Bartelink, F. Roelofsen, and F. Eschwege Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 1997 2040 2049
5. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research Lancet 348 1996 1049 1054
6. J. Papillon, J.F. Montbarbon, and J.P. Gerard Interstitial curietherapy in the conservative treatment of anal and rectal cancers Int J Radiat Oncol Biol Phys 17 1989 1161 1169
7. J.M. Hannoun-Levi, C. Ortholan, and M. Resbeut High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study) Int J Radiat Oncol Biol Phys 80 2011 712 720
8. American Joint Committee on Cancer Anal canal AJCC Cancer Staging Manual 6th ed. 2002 Springer New York 125 130
9. C. Ortholan, M. Resbeut, and J.M. Hannoun-Levi Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 study) Int J Radiat Oncol Biol Phys 82 2012 1988 1995
10. A. Dutreix, and G. Marinello The Paris system B. Pierquin, J.F. Wilson, D. Chassagne, Modern Brachytherapy 1987 Masson New York 27 42
11. D.C. Weber, J.M. Kurtz, and A.S. Allal The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy Int J Radiat Oncol Biol Phys 50 2001 675 680
12. R. James, H. Meadows, and S. Wan ACT II: the second UK phase III anal cancer trial Clin Oncol 17 2005 364 366
13. A. Niemierko Reporting and analyzing dose distributions: a concept of equivalent uniform dose Med Phys 24 1997 103 110
14. S.D. Otto, L. Lee, and H.J. Buhr Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging J Gastrointest Surg 13 2009 1292 1298
15. S.R. Puli, J.B. Reddy, and M.L. Bechtold Accuracy of endoscopic ultrasound to diagnose nodal invasion by rectal cancers: a meta-analysis and systematic review Ann Surg Oncol 16 2009 1255 1265
16. O. Dahl, A. Horn, and I. Morild Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway Cancer 66 1990 2286 2294
17. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
18. K. Bujko, M.P. Nowacki, and A. Nasierowska-Guttmejer Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer Br J Surg 93 2006 1215 1223
19. T.E. Read, J.E. Andujar, and P.F. Caushaj Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status Dis Colon Rectum 47 2004 825 831
20. S.P. Hiotis, S.M. Weber, and A.M. Cohen Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients J Am Coll Surg 194 2002 131 136